announced Thursday it received a medical cannabis license in Greece but the stock was falling following after the company posted quarterly revenue below analysts' forecasts. The company said the license, issued by the Greek government, allows the company to establish cultivation, processing and manufacturing facilities in the Thessaly region of the country, poising the company to become the leader in the European cannabis landscape. "This is a major step for Hexo as we continue to execute towards becoming a top three global cannabis company," said CEO Sebastien St-Louis.